These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 11836805

  • 21. Once versus three-times daily regimens of tobramycin treatment for pulmonary exacerbations of cystic fibrosis--the TOPIC study: a randomised controlled trial.
    Smyth A, Tan KH, Hyman-Taylor P, Mulheran M, Lewis S, Stableforth D, Prof Knox A, TOPIC Study Group.
    Lancet; ; 365(9459):573-8. PubMed ID: 15708100
    [Abstract] [Full Text] [Related]

  • 22. Serum pharmacokinetics and sputum penetration of amikacin 30 mg/kg once daily and of ceftazidime 200 mg/kg/day as a continuous infusion in cystic fibrosis patients.
    Byl B, Baran D, Jacobs F, Herschuelz A, Thys JP.
    J Antimicrob Chemother; 2001 Aug; 48(2):325-7. PubMed ID: 11481316
    [No Abstract] [Full Text] [Related]

  • 23. Sequential ciprofloxacin therapy in pediatric cystic fibrosis: comparative study vs. ceftazidime/tobramycin in the treatment of acute pulmonary exacerbations. The Cystic Fibrosis Study Group.
    Church DA, Kanga JF, Kuhn RJ, Rubio TT, Spohn WA, Stevens JC, Painter BG, Thurberg BE, Haverstock DC, Perroncel RY, Echols RM.
    Pediatr Infect Dis J; 1997 Jan; 16(1):97-105; discussion 123-6. PubMed ID: 9002118
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of once-daily tobramycin monotherapy for acute pulmonary exacerbations of cystic fibrosis: a preliminary study.
    Master V, Roberts GW, Coulthard KP, Baghurst PA, Martin A, Roberts ME, Onishko CR, Martin AJ, Linke RJ, Holmes M, Jarvinen A, Kennedy D, Colebatch KA, Hansman D, Parsons DW.
    Pediatr Pulmonol; 2001 May; 31(5):367-76. PubMed ID: 11340683
    [Abstract] [Full Text] [Related]

  • 25. Cure of Pseudomonas aeruginosa infection in neutropenic patients by continuous infusion of ceftazidime.
    Daenen S, de Vries-Hospers H.
    Lancet; 1988 Apr 23; 1(8591):937. PubMed ID: 2895853
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of inhaled amikacin as adjunct to intravenous combination therapy (ceftazidime and amikacin) in cystic fibrosis.
    Schaad UB, Wedgwood-Krucko J, Suter S, Kraemer R.
    J Pediatr; 1987 Oct 23; 111(4):599-605. PubMed ID: 3309236
    [Abstract] [Full Text] [Related]

  • 27. Cystic fibrosis, Pseudomonas aeruginosa, and selective decontamination.
    Dalzell AM, van Saene HK, Heaf DP.
    Arch Dis Child; 1990 Dec 23; 65(12):1365-7. PubMed ID: 2125405
    [Abstract] [Full Text] [Related]

  • 28. Ceftazidime in cystic fibrosis: clinical, microbiological and immunological studies.
    Cullen RT, McCrae WM, Govan J, Raeburn JA, Ingram TM.
    J Antimicrob Chemother; 1983 Jul 23; 12 Suppl A():369-75. PubMed ID: 6352647
    [Abstract] [Full Text] [Related]

  • 29. Treatment of chronic pseudomonas aeruginosa infection in cystic fibrosis patients with ceftazidime and tobramycin.
    Heilesen AM, Permin H, Koch C, Høiby N.
    Scand J Infect Dis; 1983 Jul 23; 15(3):271-6. PubMed ID: 6417770
    [Abstract] [Full Text] [Related]

  • 30. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G, Digranes A, Michalsen H, Stiris T, Bergan T, Qvigstad EK.
    Eur J Respir Dis; 1987 Oct 23; 71(4):239-43. PubMed ID: 3319661
    [Abstract] [Full Text] [Related]

  • 31. Alternative antibiotics for the treatment of Pseudomonas infections in cystic fibrosis.
    Mastella G, Agostini M, Barlocco G, Bonomi U, Borgo G, Bozzino L, Cabrini G, Cappelletti LM, Castellani L, Conforti M.
    J Antimicrob Chemother; 1983 Jul 23; 12 Suppl A():297-311. PubMed ID: 6311788
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis.
    Latzin P, Fehling M, Bauernfeind A, Reinhardt D, Kappler M, Griese M.
    J Cyst Fibros; 2008 Mar 23; 7(2):142-6. PubMed ID: 17766190
    [Abstract] [Full Text] [Related]

  • 33. [Continuous ceftazidime infusion in the treatment of Pseudomonas aeruginosa infections in a Hospital at Home Unit].
    Laghzaoui F, Murcia J, Llorens P, Portilla J.
    Enferm Infecc Microbiol Clin; 2007 Jan 23; 25(1):71-2. PubMed ID: 17261252
    [No Abstract] [Full Text] [Related]

  • 34. The use of doripenem in pediatric cystic fibrosis patients in case of meropenem shortages.
    Zobell JT, Kemper AL, Young DC.
    Pediatr Pulmonol; 2014 Mar 23; 49(3):E48-51. PubMed ID: 23661625
    [Abstract] [Full Text] [Related]

  • 35. Ceftazidime treatment of chronic Pseudomonas aeruginosa respiratory tract infection in cystic fibrosis.
    Permin H, Koch C, Høiby N, Christensen HO, Møller AF, Møller S.
    J Antimicrob Chemother; 1983 Jul 23; 12 Suppl A():313-23. PubMed ID: 6352636
    [Abstract] [Full Text] [Related]

  • 36. [Continuous intravenous home treatment of airway infections using ceftazidime administration via portable pump in patients with cystic fibrosis; a multicenter study].
    Bakker W, Vinks AA, Mouton JW, de Jonge P, Verzijl JG, Heijerman HG.
    Ned Tijdschr Geneeskd; 1993 Nov 27; 137(48):2486-91. PubMed ID: 8272124
    [Abstract] [Full Text] [Related]

  • 37. Antipseudomonal therapy in cystic fibrosis: aztreonam and amikacin versus ceftazidime and amikacin administered intravenously followed by oral ciprofloxacin.
    Schaad UB, Wedgwood-Krucko J, Guenin K, Buehlmann U, Kraemer R.
    Eur J Clin Microbiol Infect Dis; 1989 Oct 27; 8(10):858-65. PubMed ID: 2512129
    [Abstract] [Full Text] [Related]

  • 38. Cost savings and economic considerations using home intravenous antibiotic therapy for cystic fibrosis patients.
    Kane RE, Jennison K, Wood C, Black PG, Herbst JJ.
    Pediatr Pulmonol; 1988 Oct 27; 4(2):84-9. PubMed ID: 3132695
    [Abstract] [Full Text] [Related]

  • 39. Tobramycin dosing in cystic fibrosis.
    Smyth A, Touw D, Tan KH, Bertenshaw C, Stableforth D.
    Lancet; 1988 Oct 27; 365(9473):1767-8. PubMed ID: 15910946
    [No Abstract] [Full Text] [Related]

  • 40. Pharmacokinetics and pharmacodynamics of extended-infusion piperacillin/tazobactam in adult patients with cystic fibrosis-related acute pulmonary exacerbations.
    Butterfield JM, Lodise TP, Beegle S, Rosen J, Farkas J, Pai MP.
    J Antimicrob Chemother; 2014 Jan 27; 69(1):176-9. PubMed ID: 23869050
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.